Acton, MA, United States of America

Daniel M Scott



 

Average Co-Inventor Count = 6.2

ph-index = 6

Forward Citations = 128(Granted Patents)


Location History:

  • Waltham, MA (US) (1996)
  • Acton, MA (US) (2004 - 2011)
  • Weston, MA (US) (2003 - 2020)

Company Filing History:


Years Active: 1996-2020

where 'Filed Patents' based on already Granted Patents

27 patents (USPTO):

Title: The Innovations of Daniel M. Scott: A Pioneering Inventor in Biochemistry

Introduction

Daniel M. Scott is an accomplished inventor based in Acton, MA, known for his significant contributions to the field of biochemistry. With an impressive portfolio of 27 patents, Scott has made substantial advancements in drug discovery and development, particularly in the realm of targeted therapies.

Latest Patents

Among Scott's latest innovations are two notable patents. The first is focused on Bruton's tyrosine kinase inhibitors, which outlines compounds that serve as effective inhibitors of Btk. This invention encompasses compositions and methods for utilizing these compounds, demonstrating significant potential in treating various diseases. The second patent highlights heterobicyclic sphingosine 1-phosphate analogs. These compounds exhibit agonist activity at specific S1P receptors, functioning as sphingosine analogs that, upon phosphorylation, can modulate receptor activity.

Career Highlights

Daniel M. Scott has made remarkable strides in his career, having worked with renowned companies such as Biogen Idec Massachusetts, Inc. and Sunesis Pharmaceuticals, Inc. His efforts have not only advanced scientific knowledge but have also paved the way for new treatment options in the pharmaceutical industry.

Collaborations

Throughout his career, Scott has collaborated with talented professionals, including Gnanasambandam Kumaravel and Wen-Cherng Lee. These partnerships have been instrumental in driving innovation and developing groundbreaking therapies, reflecting a collaborative spirit that is crucial in the research community.

Conclusion

Daniel M. Scott exemplifies the impact that inventors can have on biochemistry and pharmaceutical advancements. With a strong patent portfolio and collaborations with esteemed colleagues, his work continues to influence the development of innovative treatments, potentially transforming patient care in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…